NeoSync
South Boston
About NeoSync
NeoSync is a clinical-stage company with a proprietary platform technology being used to develop advanced, non-invasive neuromodulation products designed to treat Major Depressive Disorder and other diseases of the Central Nervous System .(Autism, Parkinson's Disease, Anxiety, Post Traumatic Stress Disorder, etc.). The Company is led by experienced medical device executives and entrepreneurs.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.0M
- Funding stage: M&A
- Last round: Series D (Aug 2017)
- Website: neosync.com
- Phone: (781)373-1078
Industries & Categories
Clinical Trials, Information Technology, Medical
Social Profiles
Canonical: https://fsome.com/organization/neosync-163378 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.